Abstract
One of the fundamental problems in the cancer risk assessment area is the extrapolation of observed experimental results between animal species and man. Lacking detailed information on interspecies differences, it is frequently assumed that experimental results can be extrapolated between species when administered dosage is standardized as either mg/kg body weight per day (body weight scaling) or mg/m2 per day (surface area scaling). Several investigators have argued for the efficacy of one or the other of these procedures (Pinkel, 1958; Freireich et al., 1966; Crouch and Wilson, 1978; Hoel, 1979; Crump and Guess, 1980; Hogan and Hoel, 1982; MRI, 1986; FASEB, 1986; Travis and White, 1988). It is well recognized that neither of these extrapolation procedures will be exactly correct for all compounds and that when species-specific data are available, they should be used in risk assessment. In their absence, body weight or surface area extrapolations are used with the explicit knowledge that they are only approximately correct.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adolph, E. F. (1949). Quantitative relations in the physiological constitutions of mammals, Science 109: 579–585.
Andersen, M. E. (1987). Tissue Dosimetry in Risk Assessment, or What’s the Problem Here Anyway? in: Drinking Water and Health, Volume 8, Pharmacokinetics in Risk Assessment. National Academy Press, Washington, DC.
Andersen, M. E., Clewell, H. J. III, Gargas, M. L., Smith, F. A., and Reitz, R. H. (1987). Physiologically based pharmacokinetics and the risks assessment process for methylene chloride, Toxicol. Appl. Pharmacol. 87: 185–205.
Arms, A. D., and Travis, C. C. (1988). Reference Physiological Parameters In Pharmacokinetic Modeling. US Environmental Protection Agency, Washington, DC. EPA/600/6–88/004.
Benedict, F. G. (1938). Vital Energetics: A Study in Comparative Bacal Metabolism. Washington, DC, Carnegie Institute of Washington
Boxenbaum, H. (1986). Time concepts in physics, biology, and pharmacokinetics, J. Pharmaceutical Sci. 75 (11): 1053–62.
Boxenbaum, H. (1982). Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics, J. Pharmacokinet. Biopharm. 10: 201–227.
Brody, S. (1945). Bioenergetics and Growth: With Special Reference to the Efficiency Complex in Domestic Animals. Reinhold, New York. (reprinted 1964. Darien, CT: Hafner ).
Calder, W. A. (1968). Respiration and heart rates of birds at rest. Condor 70: 358–365.
Carrell, A. (1931). Physiological time, Science 74: 618–621.
Crouch, E., and Wilson R. (1978). Interspecies Comparison of Carcinogenic Potency, Journal of Toxicology and Environmental Health 5: 1095–1118.
Crump, K. S. and Guess H. A. (1980). Drinking Water and Cancer: Review of Recent Findings and Assessment of Risks. Science Research Systems Inc., Ruston, Louisiana, CBQ Contract No. EQ10AC018.
Dedrick, R. L. (1973). Animal scale-up, J. Pharmacokinetics and Biopharmaceutics 1 (5): 435–461.
Edwards, N. A. (1975). Scaling of renal functions in mammals, Comp. Biochem. Physiol. 52A: 63–66.
Federation of American Societies for Experimental Biology (FASEB) (July, 1986 ). Biological Bases for Interspecies Extrapolation of Carcinogenicity Data, (Eds. Thomas Hill, Ralph Wands, and Richard Leukroth, Jr.) Prepared for the FDA by Life Sciences Research Office of the FASEB.
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. and Skipper, H. E. (1966). Quantitative comparison of toxicity of anticancer
agents in mouse, rat, hamster, dog, monkey and man, Cancer Chemotherapy Reports 50(4): 219–244.
Gerlowski, L. E. and Jain, R. K., (1983). Physiologically based pharmacokinetic modeling: Principles and applications, J. Pharm. Science., 72: 1103–1126.
Gunther, B. and Leon de la Barra, B. (1966). On the space-time continuum in biology, Acta Physiol. Latinamerica 16: 221–231.
Guyton, A. C. (1947). Measurement of the respiratory volumes of laboratory animals, Amer. J. Physiol. 150: 70–77.
Guyton, A. C. (1971). Textbook of Medical Physiology. 4th Edition. Philadelphia, PA, W. B. Saunders Company.
Hill, A. V. (1950). The dimensions of animals and their muscular dynamics. Proc. Roy. Inst. G.B., 34: 450–471.
Hoel, D. G. (1979). Low-Dose and Species to Species Extrapolation for Chemically Induced Carcinogenesis, in: Banbury Report No. 1: Assesing Chemical Mutagens: The Risks to Humans, ed. V. McElheny. New York: Cold Spring Harbor Laboratory, pp. 135–145.
Hogan, M. and Hoel, D. G. (1982). Extrapolation to man, in: Principles of Toxicology, ed. A. W. Hayes, New York, Raven Press.
Holt, J. P., Rhode, E. A., and Kines, H. (1968). Ventricular volumes and body weight in mammals, Amer. J. Physiol. 215 (3) pp. 704–715.
Huxley, J. S. (1927). On the relation between egg-weight and body-weight in birds, J. Linnean Soc. Zoology 36: 457–466.
Jansky, L. (1961). Total cytochrome oxidase activity and its relation to basal and maximal metabolism, Nature 189: 921–922.
Jansky, L. (1963). Body organ cytochrome oxidase activity in cold-and-warmacclimated rats, Can. J. Biochem. Physiol., 41: 1847–1854.
Kleiber, M. (1932). Body size and metabolism, Hilgardia 6: 315–353.
Kleiber, M. (1961). The Fire of Life. An Introduction to Animal Energetics. New York, Wiley Publications.
Kunkel, H. O., Spalding, J. F., de Franciscis, G. and Futrell, M. F. (1956). Cytochrome oxidase activity and body weight in rats and in three species of large animals, Amer. J. Physiol., 186: 203–206.
Lindstedt, S. L. and Calder, W. A. (1981). Body size and physiological time, and longevity of homeothermic animals, The Quarterly Review of Biology 56: 1–16.
Lindstedt, S. L. (1987) Allometry: Body size constraints in animal design, in: Drinking Water and Health. Pharmacokinetics in Risk Assessment Volume 8. National Academy Press, Washington, DC.
Mathieu, O., Krauer, R., Hoppeler, H., Gehr, P., Lindstedt, S. L., Alexander, R., Taylor, C. R., and Weibel, E. R., (1981). Design of the mammalian respiratory system. VII. Scaling mitochondrial volume in skeletal muscle to body mass, Resp. Physiol., 44: 113–128.
McMahon, T. (1973). Size and shape in biology, Science 179: 1201–1204. Midwest Research Institute (MRI) (July 31, 1986 ). Risk Assessment Methodology for Hazardous Waste Management. ( Final Report. )
Prepared for the US EPA and Council on Environmental Quality.
Mordenti, J. (1986). Man versus beast: pharmacokinetic scaling in mammals, J. Pharmaceutical Science 75 (11): 1028–1040.
National Research Council (NRC) (1987). Drinking Water and Health. Volume 6. National Academy Press, Washington, DC.
National Research Council (NRC) (1986). Drinking Water and Health. Pharmacokinetics in Risk Assessment Volume 8. National Academy Press, Washington, DC.
Paustenbach, D. J., Andersen, M. E., Clewell, H. J. III, Gargas, M. L., (1988). A physiologically based pharmacokinetic model for inhaled carbon tetrachloride in the rat, Toxicol. Appl. Pharmacol.(In press.)
Pinkel, D. (1958). The use of body surface area as a criterion of drug dosage in cancer chemotherapy, Cancer Research 18 (1): 853–856.
Prothero 0. (1979). Heart weight as a function of body weight in mammals,Growth 43: 139–150.
Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans, Toxicol. Appl. Pharmacol. 73: 159–175.
Schmidt-Nielsen K. (1970). Energy metabolism, body size and problems of scaling. Fed. Proc. 29: 1524–1532.
Schmidt-Nielson, K. (1984). Scaling: Why is Animal Size So Important? Cambridge: Cambridge University Press.
Smith, R. E. (1956). Quantitative relations between liver mitochondria metabolism and total body weight in mammals, Ann. NY Acad. Sci. 62: 403–422.
Stahl, W. R. (1965). Organ weights in primate and other mammals, Science 150: 1039–1042.
Stahl, W. R. (1967). Scaling of respiratory variables in mammals, J. Appl. Physiology 48: 1052–1059.
Travis, C. C. and White, R. K., (1988). Interspecific scaling of toxicity data, Risk Analysis 8: 119–125.
Travis, C. C., White, R. K., and Ward, R. C. (1988). Interspecies extrapolation of pharmacokinetics, Fundamentals Applied Toxicology (Submitted).
Travis, C. C. (1988). Tissue dosimetry in risk assessment, Risk Analysis (Submitted).
U. S. Environmental Protection Agency (EPA) (1987). Update of the Health Assessment Document and Addendum for Dichloromethane (Methylene Chloride): Pharmacokinetics, Mechanisms of Action, and Epidemiology. EPA/600/8–87/030A.
Ward, R. C., Travis, C. C., Hetrick, D. M., Andersen, M. E., and Gargas, M. L., (1988). Pharmacokinetics of tetrachloroethylene, Toxicol. Appl. Pharmacol. 93: 108–117.
White, L., Haines, H. and Adams, T. (1968). Cardiac output related to body weight in small mammals, Comp. Biochem. Physiol. 27: 559–565.
Yates, F. E. and Kugler, P. N. (1986). Similarity principles and intrinsic geometrics: contrasting approaches to interspecies scaling, J. Pharmaceutical Sci. 75 (11): 1019–1027.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Travis, C.C. (1989). Interspecies Extrapolation. In: Travis, C.C. (eds) Biologically Based Methods for Cancer Risk Assessment. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5625-7_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5625-7_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5627-1
Online ISBN: 978-1-4684-5625-7
eBook Packages: Springer Book Archive